TNI BioTech, Inc. Signs Memorandum of Agreement to Open Pharmaceutical Plant for the Production of IRT-103 (LDN) (En)
NEW YORK, NY -- (Marketwire) -- 09/11/12 -- TNI BioTech, Inc., (PINKSHEETS: TNIB), a public company operating in the biotech sector, announced today the signing of a Memorandum of Agreement between the company and MOV-FAS S.A. to open a pharmaceutical plant in Managua, Nicaragua. TNIB acquired a number of patents from Dr. Bernard Bihari involving Low-Dose Naltrexone (LDN) for the treatment...
Διαβασε περισσότερα